Portfolio Holdings Detail for ISIN IE00BP3QZB59
Stock Name / Fund iShares Edge MSCI World Value Factor UCITS ETF
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker IWFV(GBX) LSE
ETF Ticker IS3S(EUR) F
ETF Ticker IS3S.DE(EUR) CXE
ETF Ticker IWFV.LS(GBX) CXE
ETF Ticker IWVL.LS(USD) CXE
ETF Ticker IWVL.MI(EUR) CXE
ETF Ticker IWVLz(USD) CXE
ETF Ticker IWVL(EUR) ETF Plus
ETF Ticker IWFV.L(GBP) LSE

Holdings detail for TEVA

Stock Name	Teva Pharma Industries Ltd ADR
Ticker	TEVA(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US8816242098
LEI	549300BAFGM4RC74ZJ94

Show aggregate TEVA holdings

News associated with TEVA

Medincell Reports Positive Phase 3 Safety Data For Olanzapine LAI; No PDSS Observed: (RTTNews) - Medincell SA (MEDCL.PA) reported that new long-term safety data from the completed Phase 3 SOLARIS trial support the potential of Olanzapine LAI (TEV-749) as the first long-acting olanzapine treatment option for schizophrenia, with no post-injection delirium/sedation - 2025-09-22 03:59:28
HEFA, EFA, TEVA, MNDY: Large Outflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Currency Hedged MSCI EAFE ETF (Symbol: HEFA) where we have detected an approximate $98.6 million dollar outflow -- that's a 1.5% decrease we - 2025-09-19 11:50:18
Tuesday's ETF with Unusual Volume: EFG: The iShares MSCI EAFE Growth ETF is seeing unusually high volume in afternoon trading Tuesday, with over 10.5 million shares traded versus three month average volume of about 647,000. Shares of EFG were down about 0.5% on the day. Components of that ETF with the highest volume - 2025-09-16 13:25:58
Noteworthy ETF Inflows: IDEV, CYBR, TEVA, CCEP: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core MSCI International Developed Markets ETF (Symbol: IDEV) where we have detected an approximate $366.0 million dollar inflow -- that's a 1 - 2025-09-08 12:03:35
Notable ETF Inflow Detected - IXUS, AER, TEVA, FUTU: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core MSCI Total International Stock ETF (Symbol: IXUS) where we have detected an approximate $129.6 million dollar inflow -- that's a 0.3% in - 2025-08-25 13:46:54
Billionaire Stanley Druckenmiller Sold All of His Palantir and Has Piled Into This High-Flying Drug Stock for 4 Consecutive Quarters: Key PointsQuarterly-filed Form 13Fs give investors a way to track which stocks Wall Street's best money managers are buying and selling. - 2025-08-20 04:51:00
US Bancorp DE Has $166,000 Stock Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA): US Bancorp DE lifted its stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 6.5% in the first quarter, HoldingsChannel reports. The firm owned 10,812 shares of the company’s stock after purchasing an additional 656 shares during the period. US Bancorp DE’s holdings in Teva Pharmaceutical Industries were worth $166,000 at the end […] - 2025-08-17 05:46:51
Deutsche Bank AG Increases Stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA): Deutsche Bank AG grew its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 16.9% in the 1st quarter, HoldingsChannel reports. The firm owned 2,589,607 shares of the company’s stock after buying an additional 375,064 shares during the quarter. Deutsche Bank AG’s holdings in Teva Pharmaceutical Industries were worth $39,802,000 as of its […] - 2025-08-13 05:18:59
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives $24.71 Consensus PT from Analysts: Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) has received a consensus rating of “Buy” from the eight research firms that are covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year price […] - 2025-08-04 02:43:01
Wall Street Zen Upgrades Teva Pharmaceutical Industries (NYSE:TEVA) to Buy: Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday. TEVA has been the subject of a number of other reports. JPMorgan Chase & Co. upgraded Teva Pharmaceutical Industries from a “neutral” rating […] - 2025-07-28 04:02:50
Signaturefd LLC Trims Stock Holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA): Signaturefd LLC decreased its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 28.8% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,768 shares of the company’s stock after selling 2,739 shares during the period. Signaturefd LLC’s holdings in […] - 2025-07-22 07:20:51
Head to Head Comparison: Teva Pharmaceutical Industries (NYSE:TEVA) vs. Taysha Gene Therapies (NASDAQ:TSHA): Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings. Profitability This table compares Taysha Gene […] - 2025-07-22 02:45:38
Billionaire Stanley Druckenmiller Sold His Entire Stake in Palantir and Has Loaded Up on These 2 Exceptional Stocks for 3 Consecutive Quarters: Key PointsForm 13Fs provide investors with an over-the-shoulder look at which stocks Wall Street's brightest money managers are buying and selling. - 2025-07-18 04:06:00
Bank of New York Mellon Corp Sells 11,648 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA): Bank of New York Mellon Corp lessened its position in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 0.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,609,696 shares of the company’s stock after selling 11,648 shares during […] - 2025-07-17 04:32:51
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Sold by Envestnet Asset Management Inc.: Envestnet Asset Management Inc. trimmed its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 5.7% during the first quarter, HoldingsChannel reports. The firm owned 1,921,762 shares of the company’s stock after selling 116,779 shares during the period. Envestnet Asset Management Inc.’s holdings in Teva Pharmaceutical Industries were worth $29,537,000 at the end […] - 2025-07-15 05:14:50
DekaBank Deutsche Girozentrale Decreases Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA): DekaBank Deutsche Girozentrale decreased its stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 2.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 72,127 shares of the company’s stock after selling 1,453 shares during the period. DekaBank Deutsche Girozentrale’s […] - 2025-07-14 05:34:47
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives $24.13 Consensus Price Target from Analysts: Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) have earned a consensus rating of “Buy” from the nine analysts that are presently covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average […] - 2025-07-10 02:50:52
GAMMA Investing LLC Sells 3,068 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA): GAMMA Investing LLC trimmed its stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 41.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,390 shares of the company’s stock after selling 3,068 shares during the […] - 2025-07-09 04:24:51
Teva Pharmaceutical Industries Sees Unusually Large Options Volume (NYSE:TEVA): Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) saw some unusual options trading activity on Monday. Stock investors purchased 59,369 put options on the stock. This is an increase of approximately 93% compared to the typical volume of 30,826 put options. Teva Pharmaceutical Industries Stock Down 1.0% TEVA stock opened at $16.84 on Tuesday. […] - 2025-07-08 02:20:24
Retirement Systems of Alabama Makes New Investment in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA): Retirement Systems of Alabama acquired a new position in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 401,249 shares of the company’s stock, valued at approximately $6,167,000. Other large investors […] - 2025-06-25 05:08:59
IXUS, TEVA, TME, MNDY: ETF Inflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core MSCI Total International Stock ETF (Symbol: IXUS) where we have detected an approximate $593.1 million dollar inflow -- that's a 1.3% in - 2025-06-20 12:07:30
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Holdings Reduced by QRG Capital Management Inc.: QRG Capital Management Inc. lessened its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 12.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 129,430 shares of the company’s stock after selling 18,708 shares during […] - 2025-06-20 05:38:53
Billionaire Stanley Druckenmiller Dumped His Entire Stake in Palantir and Has Piled Into This Suddenly Unstoppable Drug Stock for 3 Straight Quarters: There's nothing more valuable on Wall Street than data, and investors rarely have to dig to find something that's pertinent to the U.S. economy, the stock market, or their specific portfolio holdings. - 2025-06-16 04:06:00
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Given Consensus Recommendation of “Buy” by Brokerages: Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has been given a consensus rating of “Buy” by the ten brokerages that are presently covering the company, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average […] - 2025-06-12 05:30:57
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Sees Large Increase in Short Interest: Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 38,700,000 shares, an increase of 36.1% from the April 30th total of 28,430,000 shares. Based on an average trading volume of 12,300,000 […] - 2025-06-04 05:04:50
Monday's ETF with Unusual Volume: EFAA: The Invesco MSCI EAFE Income Advantage ETF is seeing unusually high volume in afternoon trading Monday, with over 217,000 shares traded versus three month average volume of about 30,000. Shares of EFAA were down about 0.1% on the day. Components of that ETF with the highest vo - 2025-06-02 14:56:10
B. Riley Wealth Advisors Inc. Buys New Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA): B. Riley Wealth Advisors Inc. bought a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 9,689 shares of the company’s stock, valued at approximately $214,000. Other hedge funds and other institutional […] - 2025-06-02 05:40:56
Teva Pharmaceutical Industries (NYSE:TEVA) Now Covered by Truist Financial: Truist Financial assumed coverage on shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) in a report issued on Wednesday, MarketBeat.com reports. The brokerage issued a buy rating and a $25.00 price target on the stock. TEVA has been the topic of several other reports. Barclays reduced their price target on Teva Pharmaceutical Industries from […] - 2025-05-29 03:14:53
Billionaire Stanley Druckenmiller Just Sold One of Wall Street's Hottest Stock-Split Stocks and Is Piling Into a Promising Drugmaker Instead: The amount of data investors digest daily on Wall Street can sometimes feel overwhelming. Over the last six weeks, investors have navigated their way through earnings season, a Federal Reserve Open Market Committee meeting, and President Donald Trump's regularly changing tariff a - 2025-05-28 04:06:00
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Consensus Recommendation of “Buy” from Analysts: Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has earned a consensus rating of “Buy” from the eight analysts that are presently covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price […] - 2025-05-23 06:58:47

iShares Edge MSCI World Value Factor UCITS ETF TEVA holdings

Date	Number of TEVA Shares Held	Base Market Value of TEVA Shares	Local Market Value of TEVA Shares	Change in TEVA Shares Held	Change in TEVA Base Value	Current Price per TEVA Share Held	Previous Price per TEVA Share Held
2025-09-18 (Thursday)	439,987	USD 8,117,760	USD 8,117,760	0	USD 30,799	USD 18.45	USD 18.38
2025-09-17 (Wednesday)	439,987	USD 8,086,961	USD 8,086,961	0	USD -131,996	USD 18.38	USD 18.68
2025-09-16 (Tuesday)	439,987	USD 8,218,957	USD 8,218,957	870	USD -75,963	USD 18.68	USD 18.89
2025-09-15 (Monday)	439,117	USD 8,294,920	USD 8,294,920
2025-09-12 (Friday)	439,117	USD 8,751,602	USD 8,751,602
2025-09-11 (Thursday)	439,117	USD 8,734,037	USD 8,734,037
2025-09-10 (Wednesday)	438,279	USD 8,577,120	USD 8,577,120

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TEVA by Blackrock for IE00BP3QZB59

Show aggregate share trades of TEVA

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-16 BUY 870 18.680* 16.73
2025-08-15 BUY 4,340 17.860* 16.71
2025-08-05 SELL -1,290 15.710* 16.72 Profit of 21,564 on sale
2025-07-14 SELL -1,347 16.420* 16.75 Profit of 22,563 on sale
2025-06-27 BUY 8,436 16.760* 16.75
2025-06-25 SELL -2,694 17.000* 16.75 Profit of 45,120 on sale
2025-06-02 SELL -5,160 17.260* 16.68 Profit of 86,045 on sale
2025-05-30 SELL -39,543 16.780* 16.67 Profit of 659,359 on sale
2025-05-27 SELL -5,192 17.710* 16.65 Profit of 86,428 on sale
2025-05-19 SELL -3,656 17.020* 16.64 Profit of 60,827 on sale
2025-05-15 SELL -3,632 16.870* 16.63 Profit of 60,410 on sale
2025-05-14 SELL -1,804 16.890* 16.63 Profit of 30,001 on sale
2025-04-24 SELL -918 14.720* 16.68 Profit of 15,311 on sale
2025-04-22 SELL -1,380 14.000* 16.73 Profit of 23,090 on sale
2025-04-10 BUY 1,825 12.820* 17.03
2025-04-09 BUY 1,572 14.160* 17.06
2025-04-07 SELL -7,316 13.940* 17.14 Profit of 125,410 on sale
2025-04-01 SELL -3,668 15.290* 17.23 Profit of 63,192 on sale
2025-03-28 BUY 1,830 15.080* 17.28
2025-03-21 BUY 1,818 16.100* 17.37
2025-03-19 BUY 1,825 16.290* 17.40
2025-03-11 BUY 3,650 16.100* 17.49
2025-03-07 BUY 3,630 15.360* 17.57
2025-02-28 BUY 1,813 16.460* 17.67
2025-02-20 BUY 1,817 17.000* 17.78
2025-02-03 SELL -9,045 17.350* 18.08 Profit of 163,527 on sale
2025-01-31 SELL -1,809 17.730* 18.09 Profit of 32,721 on sale
2025-01-23 SELL -1,809 21.790* 17.67 Profit of 31,965 on sale
2025-01-02 SELL -54,674 21.300* 17.56 Profit of 960,236 on sale
2024-12-09 SELL -1,822 17.600* 17.57 Profit of 32,010 on sale
2024-12-04 SELL -1,822 17.800* 17.56 Profit of 31,994 on sale
2024-11-29 SELL -3,636 16.780* 17.63 Profit of 64,089 on sale
2024-11-25 SELL -250,587 16.690* 17.81 Profit of 4,463,410 on sale
2024-11-22 SELL -2,664 17.120* 17.84 Profit of 47,538 on sale
2024-11-21 SELL -2,664 17.080* 17.88 Profit of 47,640 on sale
2024-11-05 SELL -2,658 18.770* 18.37 Profit of 48,820 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-16	BUY	870	18.680*	16.73
2025-08-15	BUY	4,340	17.860*	16.71
2025-08-05	SELL	-1,290	15.710*	16.72 Profit of 21,564 on sale
2025-07-14	SELL	-1,347	16.420*	16.75 Profit of 22,563 on sale
2025-06-27	BUY	8,436	16.760*	16.75
2025-06-25	SELL	-2,694	17.000*	16.75 Profit of 45,120 on sale
2025-06-02	SELL	-5,160	17.260*	16.68 Profit of 86,045 on sale
2025-05-30	SELL	-39,543	16.780*	16.67 Profit of 659,359 on sale
2025-05-27	SELL	-5,192	17.710*	16.65 Profit of 86,428 on sale
2025-05-19	SELL	-3,656	17.020*	16.64 Profit of 60,827 on sale
2025-05-15	SELL	-3,632	16.870*	16.63 Profit of 60,410 on sale
2025-05-14	SELL	-1,804	16.890*	16.63 Profit of 30,001 on sale
2025-04-24	SELL	-918	14.720*	16.68 Profit of 15,311 on sale
2025-04-22	SELL	-1,380	14.000*	16.73 Profit of 23,090 on sale
2025-04-10	BUY	1,825	12.820*	17.03
2025-04-09	BUY	1,572	14.160*	17.06
2025-04-07	SELL	-7,316	13.940*	17.14 Profit of 125,410 on sale
2025-04-01	SELL	-3,668	15.290*	17.23 Profit of 63,192 on sale
2025-03-28	BUY	1,830	15.080*	17.28
2025-03-21	BUY	1,818	16.100*	17.37
2025-03-19	BUY	1,825	16.290*	17.40
2025-03-11	BUY	3,650	16.100*	17.49
2025-03-07	BUY	3,630	15.360*	17.57
2025-02-28	BUY	1,813	16.460*	17.67
2025-02-20	BUY	1,817	17.000*	17.78
2025-02-03	SELL	-9,045	17.350*	18.08 Profit of 163,527 on sale
2025-01-31	SELL	-1,809	17.730*	18.09 Profit of 32,721 on sale
2025-01-23	SELL	-1,809	21.790*	17.67 Profit of 31,965 on sale
2025-01-02	SELL	-54,674	21.300*	17.56 Profit of 960,236 on sale
2024-12-09	SELL	-1,822	17.600*	17.57 Profit of 32,010 on sale
2024-12-04	SELL	-1,822	17.800*	17.56 Profit of 31,994 on sale
2024-11-29	SELL	-3,636	16.780*	17.63 Profit of 64,089 on sale
2024-11-25	SELL	-250,587	16.690*	17.81 Profit of 4,463,410 on sale
2024-11-22	SELL	-2,664	17.120*	17.84 Profit of 47,538 on sale
2024-11-21	SELL	-2,664	17.080*	17.88 Profit of 47,640 on sale
2024-11-05	SELL	-2,658	18.770*	18.37 Profit of 48,820 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TEVA

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	1,326,567	3,941	2,847,921	46.6%
2025-09-18	1,947,007	4,426	4,674,643	41.7%
2025-09-17	1,292,039	11,664	4,003,062	32.3%
2025-09-16	2,251,053	34,178	4,868,209	46.2%
2025-09-15	2,578,420	1,100	6,567,436	39.3%
2025-09-12	2,617,292	3,861	5,387,054	48.6%
2025-09-11	1,863,296	20,567	4,067,649	45.8%
2025-09-10	2,057,028	20,419	5,058,829	40.7%
2025-09-09	2,177,348	1,452	6,082,565	35.8%
2025-09-08	2,198,386	10,526	5,200,404	42.3%
2025-09-05	1,747,079	9,493	4,271,667	40.9%
2025-09-04	2,087,450	6,830	4,093,858	51.0%
2025-09-03	2,032,226	1,600	5,035,501	40.4%
2025-09-02	2,391,634	1,654	6,813,173	35.1%
2025-08-29	1,374,476	8,978	3,008,168	45.7%
2025-08-28	1,177,487	2,946	3,118,002	37.8%
2025-08-27	1,884,393	6,555	3,323,171	56.7%
2025-08-26	1,914,180	3,249	4,260,238	44.9%
2025-08-25	1,407,463	420	3,321,523	42.4%
2025-08-22	2,604,235	0	6,684,840	39.0%
2025-08-21	3,825,586	11,389	9,899,001	38.6%
2025-08-20	1,144,097	4,878	3,530,095	32.4%
2025-08-19	1,739,267	2,524	6,118,138	28.4%
2025-08-18	1,882,607	8,592	5,438,373	34.6%
2025-08-15	2,099,823	11,013	4,305,316	48.8%
2025-08-14	2,419,794	1,706	5,478,472	44.2%
2025-08-13	1,584,588	14,939	4,845,265	32.7%
2025-08-12	1,591,669	1,500	3,589,467	44.3%
2025-08-11	1,671,914	3,200	4,204,809	39.8%
2025-08-08	2,394,847	0	5,125,370	46.7%
2025-08-07	2,680,059	10,954	6,786,021	39.5%
2025-08-06	2,688,426	464,286	5,933,923	45.3%
2025-08-05	2,444,362	403	5,927,095	41.2%
2025-08-04	2,580,270	15,606	7,333,660	35.2%
2025-08-01	2,963,212	367,256	7,094,545	41.8%
2025-07-31	3,200,207	11,249	9,684,594	33.0%
2025-07-30	4,694,488	8,581	11,845,322	39.6%
2025-07-29	2,050,848	4,084	7,443,233	27.6%
2025-07-28	2,220,328	59	6,554,156	33.9%
2025-07-25	1,667,723	1,282	4,447,672	37.5%
2025-07-24	1,993,998	2,359	4,968,343	40.1%
2025-07-23	1,911,526	10,691	5,766,862	33.1%
2025-07-22	1,643,601	135	4,872,100	33.7%
2025-07-21	1,325,474	800	3,789,650	35.0%
2025-07-18	1,955,501	5	5,942,642	32.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Edge MSCI World Value Factor UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	IWFV(GBX) LSE
ETF Ticker	IS3S(EUR) F
ETF Ticker	IS3S.DE(EUR) CXE
ETF Ticker	IWFV.LS(GBX) CXE
ETF Ticker	IWVL.LS(USD) CXE
ETF Ticker	IWVL.MI(EUR) CXE
ETF Ticker	IWVLz(USD) CXE
ETF Ticker	IWVL(EUR) ETF Plus
ETF Ticker	IWFV.L(GBP) LSE